Child’s Death Leads Beijing Health Officials To Suspend Use Of Sinovac Hepatitis A Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
An expert committee of five physicians must make a report within 45 days, under regulations issued this year.
You may also be interested in...
Sinovac To Start Clinical Trials For Hep A Vaccine In Ukraine; First Overseas Steps
SHANGHAI - Sinovac has inked a deal with Ukraine-based Biolik Biopharmaceutical to conduct clinical trials for its inactivated hepatitis A vaccine Healive in Ukraine, the company announced on Sept. 15
Sinovac To Launch New Vaccines In China; Chinese Government Biggest Purchaser
SHANGHAI - Sinovac saw increased income and profits from vaccine sales, including a first order for hepatitis vaccines placed by the Chinese government during the Sichuan earthquake in the first half of the year, according to financial results for the period ended June 30
Asia Spotlight: China's Top Drug Distributors Are Soaring
On the second Monday of each month, "The Pink Sheet" provides exclusive news and commentary on the Asia biopharma market from the editors of its affiliated online publication, PharmAsia News. Register at http://pharmasianews.elsevierbi.com/PAN_Trial_LP.html for a free trial.